Chronic kidney disease: the global challenge Treatment targets in renal fibrosis, Lancet Nephrol Dial Transplant, vol.3653, issue.22, pp.331-340, 2005. ,
Obstructive nephropathy: insights from genetically engineered animals Mechanisms of tubulointerstitial fibrosis The transforming growth factor beta system in kidney disease and repair: recent progress and future directions Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases Regulation of fibroblast functions by lysophospholipid mediators: potential roles in wound healing, Overexpression of extracellular matrix proteins in renal tubulointerstitial cells by plateletactivating-factor stimulation, pp.925-937, 1989. ,
Plateletactivating factor stimulates gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-beta, J Am Soc Nephrol, vol.8, pp.1266-1275, 1997. ,
Attenuation of Folic Acid-Induced Renal Inflammatory Injury in Platelet-Activating Factor Receptor-Deficient Mice, The American Journal of Pathology, vol.168, issue.5, pp.1413-1424, 2006. ,
DOI : 10.2353/ajpath.2006.050634
Amelioration of Bleomycin-Induced Lung Fibrosis by Treatment with the Platelet Activating Factor Receptor Antagonist Web 2086 in Hamsters, Experimental Lung Research, vol.96, issue.2, pp.287-307, 1995. ,
DOI : 10.1155/S096293519200005X
Phospholipid Concentration in Lung Lavage Fluid as Biomarker for Pulmonary Fibrosis, Inhalation Toxicology, vol.89, issue.1, pp.389-393, 2006. ,
DOI : 10.1016/0041-008X(90)90109-8
Phospholipid analysis of alveolar macrophages and bronchoalveolar lavage fluid following bleomycin administration to rabbits, Lung, vol.172, issue.2, pp.91-102, 1994. ,
DOI : 10.1007/BF00185080
Effects of a New Bioactive Lipid-Based Drug Carrier on Cultured Hepatic Stellate Cells and Liver Fibrosis in Bile Duct-Ligated Rats, Journal of Pharmacology and Experimental Therapeutics, vol.321, issue.2, pp.536-543, 2007. ,
DOI : 10.1124/jpet.106.117945
Cell surface receptors in lysophospholipid signaling, Seminars in Cell & Developmental Biology, vol.15, issue.5, pp.457-465, 2004. ,
DOI : 10.1016/j.semcdb.2004.05.005
Ki16425, a Subtype-Selective Antagonist for EDG-Family Lysophosphatidic Acid Receptors, Molecular Pharmacology, vol.64, issue.4, pp.994-1005, 2003. ,
DOI : 10.1124/mol.64.4.994
The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases, Proceedings of the National Academy of Sciences, vol.103, issue.25, pp.9643-9648, 2006. ,
DOI : 10.1073/pnas.0600979103
Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior, Proceedings of the National Academy of Sciences, vol.97, issue.24, pp.97-13384, 2000. ,
DOI : 10.1073/pnas.97.24.13384
Characterization of lpa2 (Edg4) and lpa1/lpa2 (Edg2/Edg4) Lysophosphatidic Acid Receptor Knockout Mice: Signaling Deficits without Obvious Phenotypic Abnormality Attributable to lpa2, Edg4) and lpaEdg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa, pp.6921-6929, 2002. ,
DOI : 10.1128/MCB.22.19.6921-6929.2002
LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing, Nature, vol.14, issue.7038, pp.104-108, 2005. ,
DOI : 10.1074/jbc.M104441200
Emerging medicinal roles for lysophospholipid signaling, Trends in Molecular Medicine, vol.12, issue.2, pp.65-75, 2006. ,
DOI : 10.1016/j.molmed.2005.12.001
Skeletal muscle cells express the profibrotic cytokine connective tissue growth factor, which induces their dedifferentiation, 2007. ,
Regulation of connective tissue growth factor expression in the aqueous humor outflow pathway, Mol Vis, vol.12, pp.1117-1126, 2006. ,
Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins), British Journal of Pharmacology, vol.65, issue.7, pp.1172-1180, 2001. ,
DOI : 10.1038/sj.bjp.0704173
Differential involvement of the integrin-linked kinase (ILK) in RhoA-dependent rearrangement of F-actin fibers and induction of connective tissue growth factor (CTGF), Cellular Signalling, vol.18, issue.4, pp.433-440, 2006. ,
DOI : 10.1016/j.cellsig.2005.05.011
STAT3-independent inhibition of lysophosphatidic acid-mediated upregulation of connective tissue growth factor (CTGF) by cucurbitacin I, Biochemical Pharmacology, vol.72, issue.1, pp.72-104, 2006. ,
DOI : 10.1016/j.bcp.2006.04.001
Induction of Connective Tissue Growth Factor by Activation of Heptahelical Receptors. MODULATION BY Rho PROTEINS AND THE ACTIN CYTOSKELETON, Journal of Biological Chemistry, vol.275, issue.48, pp.37429-37435, 2000. ,
DOI : 10.1074/jbc.M000976200
Expression of connective tissue growth factor in human renal fibroblasts: regulatory roles of RhoA and cAMP, J Am Soc Nephrol, vol.12, pp.1853-1861, 2001. ,
Induction of connective tissue growth factor (CTGF) in human endothelial cells by lysophosphatidic acid, sphingosine-1-phosphate, and platelets, Atherosclerosis, vol.175, issue.2, pp.261-268, 2004. ,
DOI : 10.1016/j.atherosclerosis.2004.04.011
LPA1 Receptor Activation Promotes Renal Interstitial Fibrosis, Journal of the American Society of Nephrology, vol.18, issue.12, pp.3110-3118, 2007. ,
DOI : 10.1681/ASN.2007020196
URL : https://hal.archives-ouvertes.fr/inserm-00409718
Bacteria induce CTGF and CYR61 expression in epithelial cells in a lysophosphatidic acid receptor-dependent manner, International Journal of Medical Microbiology, vol.298, issue.3-4, 2007. ,
DOI : 10.1016/j.ijmm.2007.06.001
TGF-?? signaling and the fibrotic response, The FASEB Journal, vol.18, issue.7, pp.816-827, 2004. ,
DOI : 10.1096/fj.03-1273rev
Epithelial and connective tissue cell CTGF/CCN2 expression in gingival fibrosis, The Journal of Pathology, vol.287, issue.1, pp.210-59, 2006. ,
DOI : 10.1002/path.2000
Effects of Lysophosphatidic Acid on Proliferation of Stellate Cells and Hepatocytes in Culture, Biochemical and Biophysical Research Communications, vol.248, issue.2, pp.436-440, 1998. ,
DOI : 10.1006/bbrc.1998.8983
Hepatic stellate cells: a target for the treatment of liver fibrosis, Journal of Gastroenterology, vol.35, issue.9, pp.665-672, 2000. ,
DOI : 10.1007/s005350070045
Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity, Life Sciences, vol.81, issue.12, pp.81-1009, 2007. ,
DOI : 10.1016/j.lfs.2007.08.013
Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C, J Clin Gastroenterol, vol.41, pp.616-623, 2007. ,
The lysophosphatidic acid receptor LPA(1) links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak, Nat Med, 2007. ,
Lysophosphatidic Acid Prevents Renal Ischemia-Reperfusion Injury by Inhibition of Apoptosis and Complement Activation, The American Journal of Pathology, vol.163, issue.1, pp.47-56, 2003. ,
DOI : 10.1016/S0002-9440(10)63629-2
receptors reduces murine renal ischemia-reperfusion injury, American Journal of Physiology - Renal Physiology, vol.285, issue.3, pp.565-574, 2003. ,
DOI : 10.1152/ajprenal.00023.2003
The Significance of Plasma Lysophospholipids in Patients with Renal Failure on Hemodialysis., Journal of Nutritional Science and Vitaminology, vol.44, issue.6, pp.44-809, 1998. ,
DOI : 10.3177/jnsv.44.809
Abidov, [Phospholipid composition of erythrocytes in patients with chronic kidney failure], Vopr Med Khim, vol.39, pp.43-45, 1993. ,
Bioactive lysophospholipids and mesangial cell intracellular signaling pathways: role in the pathobiology of kidney disease, Histol Histopathol, vol.20, pp.603-613, 2005. ,
Lysophosphatidic acid: a novel growth and survival factor for renal proximal tubular cells, Am J Physiol, vol.273, pp.575-585, 1997. ,
Dual effect of lysophosphatidic acid on proliferation of glomerular mesangial cells, Kidney International, vol.51, issue.4, pp.1022-1027, 1997. ,
DOI : 10.1038/ki.1997.143
Effects of Lysophosphatidic Acid, a Novel Lipid Mediator, on Cytosolic Ca2+ and Contractility in Cultured Rat Mesangial Cells, Circulation Research, vol.77, issue.5, pp.77-888, 1995. ,
DOI : 10.1161/01.RES.77.5.888
Lysophosphatidic Acid and Platelet-Derived Growth Factor Synergistically Stimulate Growth of Cultured Rat Mesangial Cells, Experimental Biology and Medicine, vol.216, issue.3, pp.370-379, 1997. ,
DOI : 10.3181/00379727-216-44184
Regulation of connective tissue growth factor (ccn2; ctgf) gene expression in human mesangial cells: modulation by HMG CoA reductase inhibitors (statins), Molecular Pathology, vol.54, issue.3, pp.54-176, 2001. ,
DOI : 10.1136/mp.54.3.176
Lysophosphatidic acid-induced proliferation in opossum kidney proximal tubular cells: Role of PI 3-kinase and ERK, Kidney International, vol.56, issue.6, pp.2064-2075, 1999. ,
DOI : 10.1046/j.1523-1755.1999.00797.x
Lysophosphatidic acid-induced calcium mobilization and proliferation in kidney proximal tubular cells, Am J Physiol, vol.276, pp.191-198, 1999. ,
DOI : 10.1046/j.1523-1755.1999.00797.x
URL : http://doi.org/10.1046/j.1523-1755.1999.00797.x
Lysophosphatidic Acid Stimulates Brush Border Na+/H+ Exchanger 3 (NHE3) Activity by Increasing Its Exocytosis by an NHE3 Kinase A Regulatory Protein-dependent Mechanism, Journal of Biological Chemistry, vol.278, issue.19, pp.16494-16501, 2003. ,
DOI : 10.1074/jbc.M300580200
Mitogenic action of lysophosphatidic acid in proximal tubular epithelial cells obtained from voided human urine, Clin Sci (Lond), pp.99-561, 2000. ,
Lysophosphatidic Acid Inhibits Adipocyte Differentiation via Lysophosphatidic Acid 1 Receptor-dependent Down-regulation of Peroxisome Proliferator-activated Receptor ??2, Journal of Biological Chemistry, vol.280, issue.15, pp.14656-14662, 2005. ,
DOI : 10.1074/jbc.M412585200
URL : https://hal.archives-ouvertes.fr/inserm-00110113
Obstructive nephropathy: towards biomarker discovery and gene therapy, Nature Clinical Practice Nephrology, vol.17, issue.3, pp.157-168, 2006. ,
DOI : 10.1038/ncpneph0098
Obstructive nephropathy and renal fibrosis, American Journal of Physiology - Renal Physiology, vol.283, issue.5, pp.861-875, 2002. ,
DOI : 10.1152/ajprenal.00362.2001
Lysophosphatidic acid is a major serum noncytokine survival factor for murine macrophages which acts via the phosphatidylinositol 3-kinase signaling pathway., Journal of Clinical Investigation, vol.102, issue.4, pp.716-727, 1998. ,
DOI : 10.1172/JCI1002
Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques, Proceedings of the National Academy of Sciences, vol.101, issue.32, pp.11779-11784, 2004. ,
DOI : 10.1073/pnas.0403259101
Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis, The Journal of Cell Biology, vol.107, issue.4, pp.1359-1368, 1988. ,
DOI : 10.1083/jcb.107.4.1359
Reduction in Connective Tissue Growth Factor by Antisense Treatment Ameliorates Renal Tubulointerstitial Fibrosis, Journal of the American Society of Nephrology, vol.15, issue.6, pp.1430-1440, 2004. ,
DOI : 10.1097/01.ASN.0000130565.69170.85
Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis, American Journal of Physiology - Renal Physiology, vol.282, issue.5, pp.933-942, 2002. ,
DOI : 10.1152/ajprenal.00122.2001
Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction, Kidney International, vol.61, issue.5, pp.61-1684, 2002. ,
DOI : 10.1046/j.1523-1755.2002.00328.x
The ins and outs of lysophosphatidic acid signaling, BioEssays, vol.140, issue.8, pp.870-881, 2004. ,
DOI : 10.1002/bies.20081
Enhanced glomerular phospholipase activity in the obstructed kidney, International Urology and Nephrology, vol.258, issue.6, pp.783-790, 1995. ,
DOI : 10.1007/BF02552148
RANTES and Monocyte Chemoattractant Protein???1 (MCP-1) Play an Important Role in the Inflammatory Phase of Crescentic Nephritis, but Only MCP-1 Is Involved in Crescent Formation and Interstitial Fibrosis, The Journal of Experimental Medicine, vol.8, issue.7, pp.1371-1380, 1997. ,
DOI : 10.1056/NEJM199411103311907
BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury, pp.964-968, 2003. ,
Targeted disruption of the mouse transforming growth factor-??1 gene results in multifocal inflammatory disease, Nature, vol.359, issue.6397, pp.693-699, 1992. ,
DOI : 10.1038/359693a0